{"database": "lobbying", "table": "lobbying_activities", "rows": [[2141265, "b872087f-f13a-4d87-b016-1e0b37c2b514", "Q2", "JEFFREY J. KIMBELL & ASSOCIATES, INC.", 46038, "NEVRO CORPORATION", 2018, "second_quarter", "MMM", "Federal policy issues related to non-opioid pain therapies", "HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 40000, null, 0, 0, "2018-07-09T16:50:14.613000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2141265"], "units": {}, "query_ms": 30.984214041382074, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}